ÂÜÀòÂÒÂ×

Elaine Youngman is a Principal Scientist at Interius BioTherapeutics with a background in biochemistry, cell, and molecular biology. Elaine has extensive experience in research and academia, from directing research labs to establishing COVID-19 surveillance testing labs. Elaine has collaborated with cross-functional teams, conducted innovative research on RNA-centered gene regulation, and trained laboratory staff. Elaine's dedication to scientific discovery and operational efficiency is apparent throughout their career.